CurrentCardio
Get Weekly

Cardiovascular journalCurrentCardio coverage

American Heart Journal

What CurrentCardio has captured from this journal. The coverage figures describe CurrentCardio's coverage, not the journal's output. Figures as of 13 October 2026.

Recent
42 Briefs
past 90 days
Archive
143 Briefs
research published Jan–Dec 2026
Editorial
–
no Weekly issue published yet
Impact Factor
3.4
2025 · Journal Citation Reports

Topics

Evidence types

Shares are of the 143 Briefs CurrentCardio has covered from Am Heart J, by primary topic and study type; a Brief without a primary topic is in no topic row.

Publication activity

Latest from American Heart Journal

All coverage, newest first

  1. Am Heart J

    Pulsed field ablation with Renal denervation for persistent Atrial fibrIllation: Rationale and design of the PRAISE-AF randomized trial

    Trial designArrhythmias & EP

  2. Am Heart J

    Design and Rationale of the CLASP II TR Randomized Trial for Severe Tricuspid Regurgitation

    Trial designValvular & structural

  3. Am Heart J

    Sex-based differences in mortality and prognostic factors for infective endocarditis: insights from a retrospective cohort of 519 patients

    Cohort studyCardio-oncology & other

  4. Am Heart J

    Design and rationale of the Urine Sodium-directed Diuretic Adjustment Strategy in Heart Failure (US-DASH) trial

    Trial designHeart failure

  5. Am Heart J

    Design and baseline characteristics of the CagriSema cardiovascular outcomes trial (REDEFINE 3)

    Trial designCardiometabolic & kidney

  6. Am Heart J

    Design and rationale of the TANGO2 trial: A randomized controlled non-inferiority trial of bystander compression-only CPR versus standard CPR in out-of-hospital cardiac arrest

    Trial designAcute care & resuscitation

  7. Am Heart J

    Rationale and design of a multicenter randomized trial of adjunctive non-pulmonary vein trigger ablation in persistent atrial fibrillation: The EXPORT trial

    Trial designArrhythmias & EP

  8. Am Heart J

    Periprocedural Myocardial Infarction and Clinical Outcomes in Diffuse versus Focal Coronary Artery Disease

    Cohort studyCoronary & ACS

  9. Am Heart J

    Study protocol for The Heart Watch Study - Prognostic performance of smartwatch 12-lead ECG with advanced ECG analysis in consumer self-screening for cardiovascular disease

    Trial designArrhythmias & EP

  10. Am Heart J

    Individualized Or Conventional Transfusion Strategy During Veno-Arterial Extracorporeal Membrane Oxygenation Support (ICONE Study): Rationale and Design of a Prospective Multicenter Randomized Controlled Trial

    Trial designAcute care & resuscitation

  11. Am Heart J

    Efficacy of perioperative recombinant human brain natriuretic peptide for preventing acute kidney injury after cardiac surgery: Rationale, design, and study protocol for a multicenter, double-blind, randomized controlled trial (PROTECT-CS)

    Trial designHeart failure

  12. Am Heart J

    Cardiac Remodeling, Prognostic markers, and Cardiovascular Outcomes Across Heart Failure Phenotypes in Adults with Congenital Heart Disease

    Research articleHeart failure

  13. Am Heart J

    The Evolving Clinical Profile of Patients with Repaired Tetralogy of Fallot Undergoing Pulmonary Valve Replacement

    Cohort studyCongenital

  14. Am Heart J

    Single vs. dual antiplatelet therapy in elderly or HBR patients undergoing percutaneous interventions with drug-coated balloons: design and rationale of PICCOLETO IV-EPIC 38 study

    Trial designCoronary & ACS

  15. Am Heart J

    Temporal trends and clinical characteristics of drug-coated balloon angioplasty for de novo coronary lesions: A 6-year analysis from the ORPKI registry

    Cohort studyCoronary & ACS

  16. Am Heart J

    Determinants of postdischarge LDL-C testing and target attainment after acute coronary syndrome: A 10-year population-based study

    Cohort studyCoronary & ACS

  17. Am Heart J

    Accuracy of indirect Fick method for systemic flow calculation in adults with a Fontan circulation

    Research articleCongenital

  18. Am Heart J

    Rural–urban differences for integrated first responder and drone automated external defibrillator delivery in North Carolina

    Research articleAcute care & resuscitation

  19. Am Heart J

    Incidence, medical therapy, and outcomes in heart failure with improved ejection fraction across guideline definitions

    Cohort studyHeart failure

  20. Am Heart J

    Clinical and economic outcomes in diagnostic-naïve Medicare fee-for-service beneficiaries managed with alert-based ambulatory cardiac monitors: The CAMELOT-ALERT study

    Cohort studyArrhythmias & EP

  21. Am Heart J

    Clinical outcomes associated with recurrent compared to first-time myocardial infarction

    Cohort studyCoronary & ACS

  22. Am Heart J

    Age-specific coronary outcomes in subacute Kawasaki disease

    Research articleCoronary & ACS

  23. Am Heart J

    Cardiorespiratory fitness in children with surgically corrected congenital heart disease: Exercise testing profiles and biventricular function

    Cohort studyCongenital

  24. Am Heart J

    High-sensitivity HEART Pathway one-and-done troponin strategy is safe and effective

    Cohort studyCoronary & ACS

  25. Am Heart J

    Guideline-directed medical therapy and clinical outcomes in adults with Fontan palliation and systemic ventricular systolic dysfunction

    Cohort studyCongenital

  26. Am Heart J

    Health status relationship to ischemia and coronary artery disease severity in the ISCHEMIA trial

    Secondary analysisCoronary & ACS

  27. Am Heart J

    Comparative effectiveness of influenza vaccination dosing strategies for cardiovascular protection: A systematic review and network meta-analysis of randomized controlled trials

    Meta-analysisCardio-oncology & other

  28. Am Heart J

    Mavacamten monotherapy in obstructive hypertrophic cardiomyopathy: An integrated analysis of phase 3 clinical trials

    Research articleHeart failure

  29. Am Heart J

    Cardiac allograft vasculopathy and secondary outcomes at 1-year in heart transplantation from circulatory death donors

    Cohort studyHeart failure

  30. Am Heart J

    Cleaner air for lower cardiometabolic risk: Protocol for a double-blind, randomized, sham-controlled trial of HEPA filtration in adults with prediabetes

    Trial designCardiometabolic & kidney

  31. Am Heart J

    Dental procedures and associated risk of infective endocarditis

    Research articleCardio-oncology & other

  32. Am Heart J

    Recurrent myocardial infarction identified by centralized troponin review: Insights from the MINT trial

    Randomised controlled trialCoronary & ACS

  33. Am Heart J

    Pregnancy outcomes in women with a history of myocarditis

    Cohort studyCardio-oncology & other

  34. Am Heart J

    HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics

    Trial designPrevention & lipids

  35. Am Heart J

    Efficacy and safety of revascularization in patients with chronic limb-threatening ischemia by kidney function

    Secondary analysisAortic & peripheral

  36. Am Heart J

    Efficacy and safety of human albumin combined with furosemide in acute decompensated heart failure with hepatic dysfunction

    Randomised controlled trialHeart failure

  37. Am Heart J

    Impact of estimated total blood volume on NT-proBNP response to angiotensin receptor–neprilysin inhibition in acute heart failure: Insights from the PREMIER study

    Secondary analysisHeart failure

  38. Am Heart J

    Reconsidering fibrinolysis in selected patients with non–ST-elevation acute coronary syndrome: A hypothesis-generating, research-based framework

    Research articleCoronary & ACS

  39. Am Heart J

    Rationale, design, and experiences from the vanguard phase of the bariatric surgery for the reduction of cardiovascular events (BRAVE) trial

    Trial designCardiometabolic & kidney

  40. Am Heart J

    Intensive blood-pressure control for the prevention of major cardiovascular events in patients with type 2 diabetes: Rationale, design and baseline characteristics of the OPTIMAL-DIABETES randomized trial

    Trial designHypertension

All 143 Briefs in ExploreShowing the 40 most recently published